Dow announces results from 2026 Annual Stockholder Meeting
Get Alerts DOW Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 4.7%
Revenue Growth %: +18.7%
Join SI Premium – FREE
- All director nominees re-elected for one-year terms
- Board declares quarterly dividend of
35 cents per share
Today stockholders elected
Stockholders also approved all other matters presented at the meeting, including:
- An advisory resolution on executive compensation
- A one-year frequency for future advisory votes to approve executive compensation
- Approval of the amendment to the Company's 2019 Stock Incentive Plan to increase the number of shares available for issuance
- Ratification of the appointment of Deloitte & Touche LLP as Dow's independent auditor for 2026
The meeting will be available via webcast replay on Dow's website.
Following the Company's 2026 Annual Meeting of Stockholders, the Board of Directors declared a quarterly dividend of
About Dow
Dow (NYSE: DOW) is one of the world's leading materials science companies, serving customers in high-growth markets such as packaging, infrastructure, mobility and consumer applications. Our global breadth, asset integration and scale, customer-focused innovation and leading business positions enable us to achieve profitable growth and help deliver a sustainable future. We operate manufacturing sites in 29 countries and employ approximately 34,600 people. Dow delivered sales of approximately
For further information, please contact:
Investors:
[email protected]
Media:
[email protected]
X: https://twitter.com/DowNewsroom
Facebook: https://www.facebook.com/dow/
LinkedIn: http://www.linkedin.com/company/dow-chemical
Instagram: http://instagram.com/dow_official
Cautionary Statement about Forward-Looking Statements
Certain statements in this press release are "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "opportunity," "outlook," "plan," "project," "seek," "should," "strategy," "target," "will," "will be," "will continue," "will likely result," "would," and similar expressions, and variations or negatives of these words or phrases.
Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow's control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow's products; Dow's expenses, future revenues and profitability; any sanctions, export restrictions, supply chain disruptions or increased economic uncertainty related to the ongoing conflicts between
Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" contained in the Company's Annual Report on Form 10-K for the year ended
®TM Trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow
View original content to download multimedia:https://www.prnewswire.com/news-releases/dow-announces-results-from-2026-annual-stockholder-meeting-302738597.html
SOURCE The Dow Chemical Company
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Genprex receives Canadian patent notice for Reqorsa combo therapy
- CA4US Launches Immigrant Small Business Week to Celebrate California's Immigrant Entrepreneurs
- Dyne Therapeutics adds Barry Greene to its board of directors
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Twitter, Dividend, LayoffsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share